What Has Been the Growth of the Veterinary Antimicrobial Susceptibility Testing Market So Far?
The veterinary antimicrobial susceptibility testing market has seen considerable growth due to a variety of factors.
• In recent times, the market size of veterinary antimicrobial susceptibility testing has seen robust growth. The market is set to increase from $37.12 billion in 2024 to $39.71 billion in 2025, registering a compound annual growth rate (CAGR) of 7.0%. Factors such as environmental considerations, the need for precision medicine, the one health approach, consumer awareness, and the rise in companion animal healthcare have contributed to this growth during the historical period.
What Are the Future Growth Projections for the Veterinary Antimicrobial Susceptibility Testing Market?
The Veterinary Antimicrobial Susceptibility Testing market is expected to maintain its strong growth trajectory in upcoming years.
• Over the following years, the veterinary antimicrobial susceptibility testing market is predicted to experience robust expansion. The market is projected to increase to $53.96 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%.
The anticipated growth during the forecasted period can be credited to factors such as mitigation of antibiotic resistance, regulatory demands, influence of global health events, and a rise in pet ownership. The forecast period also highlights major trends such as innovative solutions, regulatory focus, control of zoonotic diseases, and standards in the livestock industry.
What Are The Core Factors Supporting Growth In The Veterinary Antimicrobial Susceptibility Testing Market?
The veterinary antimicrobial susceptibility testing market is anticipated to grow due to the escalating frequency of zoonotic diseases. A zoonotic disease constitutes an infectious disease that humans can contract from other animals and vice versa. The surge in such diseases necessitates the need for testing to ascertain the most effective animal drugs. Veterinary antimicrobial susceptibility testing assists in selecting the most optimal medication to curb bacterial infections in animals, informed by past treatments among other factors. For instance, in July 2022, the World Health Organization reported that there was a 64% increase in zoonotic cases in Africa, as pointed out by a US government agency. Additionally, there is a notable surge in zoonotic diseases both globally and in India. Such emerging infectious diseases account for 60% of human cases, with a sizable 816 out of 1407 human pathogens being zoonotic. Hence, the escalating frequency of zoonotic diseases is a major factor propelling the growth of the veterinary antimicrobial susceptibility testing market.
What Are The Major Segments Within The Global Veterinary Antimicrobial Susceptibility Testing Market?
The veterinary antimicrobial susceptibility testing market covered in this report is segmented –
1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users
Subsegments:
1) By Disks And Plates: Antibiotic Disks, Agar Plates
2) By Culture Media: Selective Culture Media, General Purpose Media
3) By Accessories And Consumables: Incubators, Sterilization Equipment, Pipettes And Reagents
4) By Automated AST (Antimicrobial Susceptibility Test) Instruments: Fully Automated Systems, Semi-Automated Systems
Pre-Book The Veterinary Antimicrobial Susceptibility Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Veterinary Antimicrobial Susceptibility Testing Market?
The advent of technological innovations has become a key trend gaining momentum in the veterinary antimicrobial susceptibility testing market. Major industry players are focusing on the development of new technologies to maintain their market standing. The market has recently seen the application of advanced imaging methods and algorithms for more precise, dependable, and swift veterinary AST (antimicrobial susceptibility testing). For example, in March 2022, bioMérieux, a biotechnology organization based in France, was granted FDA 510(k) clearance for its new VITEK MS PRIME, a MALDI- TOF1 type mass spectrometry identification system. Following the receipt of the FDA 510(k) clearance, the system is now available for commercial use in countries that recognize CE-marking, as well as in the United States. It provides rapid and accurate identification of pathogens, promoting quicker and more pinpointed antimicrobial therapy.
Who Are the Key Players In The Veterinary Antimicrobial Susceptibility Testing Market?
Major companies operating in the veterinary antimicrobial susceptibility testing market include:
• BioMérieux SA
• Becton
• Dickinson and Company
• Bio-Rad Laboratories
• Bruker Corporation
• Condalab SA
• FASTinov SA
• Hardy Diagnostics Co.
• HiMedia Laboratories
• Liofilchem Srl
• Mast Group Ltd.
• Neogen Corporation
• SSI Diagnostica A/S
• Synbiosis
• Thermo Fisher Scientific Inc.
• Accelerate Diagnostics Inc.
• Alifax S.r.l.
• Biogal Galed Labs Ltd.
• Creative Diagnostics
• Danaher Corporation
• Eurofins Scientific SE
• IDEXX Laboratories Inc.
• Merck Co. & KGaA
• Microbiologics Inc.
• QIAGEN N.V.
• R-Biopharm AG
• T2 Biosystems Inc.
• Vetoquinol S.A.
• Virbac Inc.
• Zoetis Inc.
What Is The Most Dominant Region In The Veterinary Antimicrobial Susceptibility Testing Market?
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2024. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
